BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17137715)

  • 1. A monoclonal antibody inhibits gelatinase B/MMP-9 by selective binding to part of the catalytic domain and not to the fibronectin or zinc binding domains.
    Martens E; Leyssen A; Van Aelst I; Fiten P; Piccard H; Hu J; Descamps FJ; Van den Steen PE; Proost P; Van Damme J; Liuzzi GM; Riccio P; Polverini E; Opdenakker G
    Biochim Biophys Acta; 2007 Feb; 1770(2):178-86. PubMed ID: 17137715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade.
    Vandooren J; Van den Steen PE; Opdenakker G
    Crit Rev Biochem Mol Biol; 2013; 48(3):222-72. PubMed ID: 23547785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies specific for natural human neutrophil gelatinase B used for affinity purification, quantitation by two-site ELISA and inhibition of enzymatic activity.
    Paemen L; Martens E; Masure S; Opdenakker G
    Eur J Biochem; 1995 Dec; 234(3):759-65. PubMed ID: 8575432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of gelatinase B/matrix metalloproteinase-9 activity comparison of a peptidomimetic and polyhistidine with single-chain derivatives of a neutralizing monoclonal antibody.
    Hu J; Van den Steen PE; Houde M; Ilenchuk TT; Opdenakker G
    Biochem Pharmacol; 2004 Mar; 67(5):1001-9. PubMed ID: 15104254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The isolation, characterization, and molecular cloning of a 75-kDa gelatinase B-like enzyme, a member of the matrix metalloproteinase (MMP) family. An avian enzyme that is MMP-9-like in its cell expression pattern but diverges from mammalian gelatinase B in sequence and biochemical properties.
    Hahn-Dantona EA; Aimes RT; Quigley JP
    J Biol Chem; 2000 Dec; 275(52):40827-38. PubMed ID: 11010969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of amino acid residues of the matrix metalloproteinase-2 essential for its selective inhibition by beta-amyloid precursor protein-derived inhibitor.
    Higashi S; Miyazaki K
    J Biol Chem; 2008 Apr; 283(15):10068-78. PubMed ID: 18238779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase.
    Shoari A; Rasaee MJ; Kanavi MR; Daraei B
    J Cell Biochem; 2019 Dec; 120(12):19699-19711. PubMed ID: 31270859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroxamate-based peptide inhibitors of matrix metalloprotease 2.
    Jani M; Tordai H; Trexler M; Bányai L; Patthy L
    Biochimie; 2005; 87(3-4):385-92. PubMed ID: 15781326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification and characterization of catalytic domains of gelatinase A with or without fibronectin insert for high-throughput inhibitor screening.
    Cheng D; Shen Q; Nan F; Qian Z; Ye QZ
    Protein Expr Purif; 2003 Jan; 27(1):63-74. PubMed ID: 12509986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors.
    Van den Steen PE; Van Aelst I; Hvidberg V; Piccard H; Fiten P; Jacobsen C; Moestrup SK; Fry S; Royle L; Wormald MR; Wallis R; Rudd PM; Dwek RA; Opdenakker G
    J Biol Chem; 2006 Jul; 281(27):18626-37. PubMed ID: 16672230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction, expression, and characterization of a baculovirally expressed catalytic domain of human matrix metalloproteinase-9.
    Sadatmansoori S; MacDougall J; Khademi S; Cooke LS; Guarino L; Meyer EF; Forough R
    Protein Expr Purif; 2001 Dec; 23(3):447-52. PubMed ID: 11722182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The matrix metalloproteinase 9 (mmp-9) hemopexin domain is a novel gelatin binding domain and acts as an antagonist.
    Roeb E; Schleinkofer K; Kernebeck T; Pötsch S; Jansen B; Behrmann I; Matern S; Grötzinger J
    J Biol Chem; 2002 Dec; 277(52):50326-32. PubMed ID: 12384502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structures of MMP-9 complexes with five inhibitors: contribution of the flexible Arg424 side-chain to selectivity.
    Tochowicz A; Maskos K; Huber R; Oltenfreiter R; Dive V; Yiotakis A; Zanda M; Pourmotabbed T; Bode W; Goettig P
    J Mol Biol; 2007 Aug; 371(4):989-1006. PubMed ID: 17599356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of structural elements important for matrix metalloproteinase type V collagenolytic activity as revealed by chimeric enzymes. Role of fibronectin-like domain and active site of gelatinase B.
    O'Farrell TJ; Pourmotabbed T
    J Biol Chem; 2000 Sep; 275(36):27964-72. PubMed ID: 10823838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hemopexin-like domain (C domain) of human gelatinase A (matrix metalloproteinase-2) requires Ca2+ for fibronectin and heparin binding. Binding properties of recombinant gelatinase A C domain to extracellular matrix and basement membrane components.
    Wallon UM; Overall CM
    J Biol Chem; 1997 Mar; 272(11):7473-81. PubMed ID: 9054449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-hematin interaction with the hemopexin domain of gelatinase B/MMP-9 provokes autocatalytic processing of the propeptide, thereby priming activation by MMP-3.
    Geurts N; Martens E; Van Aelst I; Proost P; Opdenakker G; Van den Steen PE
    Biochemistry; 2008 Feb; 47(8):2689-99. PubMed ID: 18237197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition of peptide inhibitors from a synthetic peptide library by targeting gelatinase B/matrix metalloproteinase-9 (MMP-9) and TNF-α converting enzyme (TACE/ADAM-17).
    Qiu Z; Yan M; Li Q; Liu D; Van den Steen PE; Wang M; Opdenakker G; Hu J
    J Enzyme Inhib Med Chem; 2012 Aug; 27(4):533-40. PubMed ID: 21827363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential induction of gelatinase B (MMP-9) and gelatinase A (MMP-2) in T lymphocytes upon alpha(4)beta(1)-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin.
    Yakubenko VP; Lobb RR; Plow EF; Ugarova TP
    Exp Cell Res; 2000 Oct; 260(1):73-84. PubMed ID: 11010812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific collagenolysis by gelatinase A, MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain.
    Patterson ML; Atkinson SJ; Knäuper V; Murphy G
    FEBS Lett; 2001 Aug; 503(2-3):158-62. PubMed ID: 11513874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of collagenase/gelatinase activity from basement-membrane fibronectin--isolation after limited proteolysis of a bovine lens capsule and molecular definition of this thiol-dependent zinc metalloproteinase.
    Boudjennah L; Dalet-Fumeron V; Pagano M
    Eur J Biochem; 1998 Jul; 255(1):246-54. PubMed ID: 9692925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.